FDA Inspection 880413 — PolyPeptide SA
The FDA completed an inspection of PolyPeptide SA on May 30, 2014 in Braine-L'Alleud. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 30, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Braine-L'Alleud (Belgium)